China Resources Pharmaceutical: Jiangzhong Pharmaceutical's first-quarter revenue is approximately RMB 1.227 billion, a year-on-year decrease of 8.74%
智通財經 APP 訊，華潤醫藥公佈江中藥業 2024 年第一季度業績，營業總收入約 12.27 億元，同比減少 8.74%;淨利潤約 2.85 億元，同比增長 9.55%。
智通財經 APP 訊，華潤醫藥 (03320) 公佈江中藥業 2024 年第一季度業績，營業總收入約 12.27 億元，同比減少 8.74%;淨利潤約 2.85 億元，同比增長 9.55%。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments